SEC Tracker
Get the app

Exagen XGN

Exagen reports $6.34 million net loss for Q3 2026

Exagen (XGN) filed a 10-Q with the SEC on Nov 10, 2026, 9:02 am ET. Source: the filing on SEC EDGAR.

Form
10-Q
Filed
Importance
Notable
  1. Revenue of $18.42 million for the three months ended Sep 30, 2026
  2. Net loss of $6.34 million for the three months ended Sep 30, 2026
  3. Cash and equivalents of $28.09 million as of Sep 30, 2026

Written from the 10-Q on EDGAR. AI can make mistakes. Check the filing.

Get the appView on EDGAR

Get an email when Exagen files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

What changed since last quarter

No new risk factors or legal mentions.

Compared with the 10-Q for the period ended Jun 30, 2026.

Key numbers from the XBRL in this filing and the previous one.
This filingPreviousChange QoQ
Revenue$18.42M$19.94M−7.6%
Operating income and margin−$4.41M · -23.9%−$1.72M · -8.6%−156%, margin −15.3 pts
Net income−$6.34M−$3.2M−98%
Operating cash flow−$2.58M$3.99M−165%
Cash$28.09M$24.59M+14%

Data on this page was fetched . The filing on SEC.gov is the record.